Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05468580

Coeliac Artery Release or Sham Operation

Led by Medisch Spectrum Twente · Updated on 2026-03-16

70

Participants Needed

1

Research Sites

291 weeks

Total Duration

On this page

Sponsors

M

Medisch Spectrum Twente

Lead Sponsor

M

Medical School Medisch Spectrum Twente

Collaborating Sponsor

AI-Summary

What this Trial Is About

In patients with Median Arcuate Ligament Syndrome (MALS), significant external compression of the coeliac artery (CA) by the median arcuate ligament (MAL) increasing mucosal ischemia (1,2) is assumed to cause chronic disabling postprandial abdominal pain, weight loss, and consequently lethargy and social deprivation (3,8). The majority of these patients have had a long medical journey before the diagnosis MALS is considered resulting in a substantial burden of disease and high healthcare and societal costs. Although a Systematic Review have shown a sustainable symptom relief of 68% and a significant and durable improvement of quality of life after surgical treatment for MALS (4), there is still no (inter)national consensus on the existence and treatment of MALS (1, 5, 6, 7). Two recent guidelines (3, 8) concluded that patients with MALS might be considered for surgical CA release (Recommendation 25 GRADE 2D; expert agreement 96%, Terlouw 2020). To end the ongoing debate and to enable the development of evidence-based guidelines for the management of MALS, both guideline committees recommend to perform a blinded, randomised controlled trial comparing a CA release with a sham operation. The proposed Coeliac Artery Release or Sham Operation study will either underline the usefulness of eCAR as a minimal invasive (cost)effective treatment for MALS or it will prohibit a meaningless intervention in patients with disabling abdominal symptoms. If the CARoSO study proves that the treatment of MALS by eCAR is effective, to 490 patients with chronic disabling abdominal symptoms per year can be treated in the Netherlands. Effective treatment of MALS is expected to result in mean health gain of 6.05 Quality Adjusted Life Years (QALYs)/patient and has the potency to reduce the substantial productivity loss and healthcare consumption caused by MALS, resulting in a saving up to M€4.3/year. The outcome of the CARoSO study will be translated into strong recommendations in the coming updates of the relevant (inter)national multidisciplinary guidelines and will be adapted in daily practice.

CONDITIONS

Official Title

Coeliac Artery Release or Sham Operation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with a confirmed diagnosis of MALS by a multidisciplinary team including a vascular surgeon, gastroenterologist, and radiologist
  • Typical symptoms include post-meal abdominal pain plus at least two of the following: dietary changes, unexplained weight loss, or unexplained diarrhea
  • Imaging showing 70% or greater narrowing of the coeliac artery at the median arcuate ligament by two techniques, including inspiratory and expiratory CT scans with 1mm slices
  • Abdominal ultrasound showing no other common abnormalities
  • Gastroscopy or duodenoscopy without abnormalities, except findings compatible with mucosal ischemia
Not Eligible

You will not qualify if you...

  • Patients not suitable for endoscopic coeliac artery release, such as those with previous surgery in the area
  • Pregnancy
  • Previous endovascular or surgical intervention on the visceral arteries
  • Significant narrowing of the superior or inferior mesenteric arteries

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Medisch Spectrum Twente

Enschede, Overijssel, Netherlands

Actively Recruiting

Loading map...

Research Team

F

Floor FM Metz, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here